Matches in Wikidata for { <http://www.wikidata.org/entity/Q81734951> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q81734951 description "artículu científicu espublizáu en mayu de 2005" @default.
- Q81734951 description "im Mai 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81734951 description "scientific article published on 09 May 2005" @default.
- Q81734951 description "wetenschappelijk artikel" @default.
- Q81734951 description "наукова стаття, опублікована в травні 2005" @default.
- Q81734951 name "Fabry disease in patients with end-stage renal failure: the potential benefits of screening" @default.
- Q81734951 name "Fabry disease in patients with end-stage renal failure: the potential benefits of screening" @default.
- Q81734951 type Item @default.
- Q81734951 label "Fabry disease in patients with end-stage renal failure: the potential benefits of screening" @default.
- Q81734951 label "Fabry disease in patients with end-stage renal failure: the potential benefits of screening" @default.
- Q81734951 prefLabel "Fabry disease in patients with end-stage renal failure: the potential benefits of screening" @default.
- Q81734951 prefLabel "Fabry disease in patients with end-stage renal failure: the potential benefits of screening" @default.
- Q81734951 P1433 Q81734951-C1401E0E-05E5-4942-86CA-B7F1E99D8845 @default.
- Q81734951 P1476 Q81734951-3170F6DB-623D-47BA-8846-A8C21660B05C @default.
- Q81734951 P2093 Q81734951-0406E4E6-7B5B-45BD-A3C3-281022547873 @default.
- Q81734951 P2093 Q81734951-04916DAF-0925-4F9B-BC1B-649A3721BF8B @default.
- Q81734951 P2093 Q81734951-12324ECA-E72D-484F-B75D-29AC77613F4A @default.
- Q81734951 P2093 Q81734951-421179DB-E00A-4A5C-9C87-50F896E4F0AF @default.
- Q81734951 P2093 Q81734951-5FAB48F1-7BD5-4911-8467-5C44AB52A14D @default.
- Q81734951 P2093 Q81734951-6744EF6D-5B39-4A3F-896B-7233472DE015 @default.
- Q81734951 P2093 Q81734951-A845F02C-CF7B-4154-A712-370BF5191ED4 @default.
- Q81734951 P2093 Q81734951-B35685E5-36BB-45E4-9132-1B897A71E5C4 @default.
- Q81734951 P304 Q81734951-FF38AA86-F84E-4B25-8202-F2740BF46589 @default.
- Q81734951 P31 Q81734951-DBFBA00F-03C7-4C88-BAE2-C2E77BA10C54 @default.
- Q81734951 P356 Q81734951-13AFDFC7-F906-4D53-AA3E-ED868C445550 @default.
- Q81734951 P433 Q81734951-F1D42BCA-2252-4204-82AC-625390F654C7 @default.
- Q81734951 P478 Q81734951-FA6EBB91-D8CD-4057-9C1E-7CADEE634BEC @default.
- Q81734951 P577 Q81734951-3758C686-8DBB-44BF-A7DD-688026C05BEC @default.
- Q81734951 P698 Q81734951-9B07D791-1FCC-4ACC-BC6A-EAEC3891A87F @default.
- Q81734951 P921 Q81734951-B0E8745F-DA05-4D87-AAE6-FFC8F9C924DB @default.
- Q81734951 P356 000085709 @default.
- Q81734951 P698 15886492 @default.
- Q81734951 P1433 Q15745443 @default.
- Q81734951 P1476 "Fabry disease in patients with end-stage renal failure: the potential benefits of screening" @default.
- Q81734951 P2093 "Adrian Enica" @default.
- Q81734951 P2093 "Gabriel Choukroun" @default.
- Q81734951 P2093 "Gisèle Plaza" @default.
- Q81734951 P2093 "Isabelle Champenois" @default.
- Q81734951 P2093 "Philippe Jaeger" @default.
- Q81734951 P2093 "Robert Unwin" @default.
- Q81734951 P2093 "Soumeya Bekri" @default.
- Q81734951 P2093 "Thomas Ghafari" @default.
- Q81734951 P304 "c33-8" @default.
- Q81734951 P31 Q13442814 @default.
- Q81734951 P356 "10.1159/000085709" @default.
- Q81734951 P433 "1" @default.
- Q81734951 P478 "101" @default.
- Q81734951 P577 "2005-05-09T00:00:00Z" @default.
- Q81734951 P698 "15886492" @default.
- Q81734951 P921 Q615645 @default.